THRIVENT FINANCIAL FOR LUTHERANS - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,249
+16.9%
82,553
-4.5%
0.01%
+25.0%
Q2 2023$1,924
-6.5%
86,483
-8.9%
0.00%
-20.0%
Q1 2023$2,057
+3.1%
94,948
-3.4%
0.01%0.0%
Q4 2022$1,996
-99.9%
98,275
-0.3%
0.01%
-28.6%
Q3 2022$2,526,000
+13.1%
98,537
+4.9%
0.01%
+16.7%
Q2 2022$2,234,000
+27.8%
93,949
+21.0%
0.01%
+100.0%
Q1 2022$1,748,000
+14.3%
77,614
+0.5%
0.00%0.0%
Q4 2021$1,529,000
-7.9%
77,236
-8.4%
0.00%0.0%
Q3 2021$1,660,000
-12.1%
84,334
-1.7%
0.00%
-25.0%
Q2 2021$1,888,000
-8.5%
85,811
-1.1%
0.00%
-20.0%
Q1 2021$2,063,000
-8.9%
86,731
+0.2%
0.01%0.0%
Q4 2020$2,264,000
+50.8%
86,543
+0.4%
0.01%
+25.0%
Q3 2020$1,501,000
+3.4%
86,237
-0.1%
0.00%0.0%
Q2 2020$1,452,000
+41.7%
86,332
+0.2%
0.00%0.0%
Q1 2020$1,025,000
+3.4%
86,200
+5.3%
0.00%
+33.3%
Q4 2019$991,000
-13.8%
81,897
+0.7%
0.00%
-25.0%
Q3 2019$1,149,000
+25.8%
81,299
-0.7%
0.00%
+33.3%
Q2 2019$913,000
-3.2%
81,902
+2.0%
0.00%0.0%
Q1 2019$943,000
-4.2%
80,286
+9.0%
0.00%
-25.0%
Q4 2018$984,000
-2.6%
73,661
+2.2%
0.00%
+33.3%
Q3 2018$1,010,000
-2.0%
72,041
+9.8%
0.00%0.0%
Q2 2018$1,031,000
-2.5%
65,612
+2.2%
0.00%
-25.0%
Q1 2018$1,057,000
+2.5%
64,229
+12.6%
0.00%
+33.3%
Q4 2017$1,031,00057,0630.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders